oa South African Family Practice - Symbicord(R) Maintenance and Reliever Treatment : a SMART new treatment standard for greater overall asthma control? : press release

Volume 50, Issue 3
  • ISSN : 2078-6190
  • E-ISSN: 2078-6204



Symbicord(R) SMART (as-needed budesonide-formoterol combination) achieved a 45% reduction in severe exacerbations compared with terbutaline, partly due to formetorol's rapid- and long-acting effect. This was achieved with less recourse to additional maintenance ICS than seen in studies yielding far smaller reductions, possibly because declining lung-tissue concentrations of maintenance ICS may benefit from timely supplementation.

Loading full text...

Full text loading...


Article metrics loading...


This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error